A 72-year-old male treated with flutamide for metastatic prostate cancer developed lethargy and confusion. He was noted to be icteric and his liver enzymes were elevated. Within a week of dicontinuing the medication, the patient's mental status and liver function returned to normal. Although flutamide-induced near fatal liver dysfunction has been described, progression to encephalopathy is a rare occurrence. Based on a review of the literature, management guidelines for the use of flutamide are suggested.
|Translated title of the contribution||Hepatic encephalopathy secondary to administra-tion of flutamide for prostate cancer|
|Number of pages||3|
|State||Published - Dec 1 1996|
- Hepatic encephalopathy
- Prostate cancer
ASJC Scopus subject areas